Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Quetiapine 300mg modified-release tablets |
BNF code | 0402010ABAAAXAX |
Virtual Therapeutic Moiety | Quetiapine |
Date identifier became valid | 22 Sep 2023 |
Previous product identifier | 426401009 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Quetiapine fumarate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 386850001 |
Strength value numerator | 300.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tabletmodified-release.oral |
Dose Form | |
Formulation | Modified-release tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Atrolak XL 300mg tablets (Accord-UK Ltd) | |
Biquelle XL 300mg tablets (Aspire Pharma Ltd) | |
Brancico XL 300mg tablets (Zentiva Pharma UK Ltd) | |
Mintreleq XL 300mg tablets (Aristo Pharma Ltd) | |
Quetiapine 300mg modified-release tablets (A A H Pharmaceuticals Ltd) | |
Quetiapine 300mg modified-release tablets (Zentiva Pharma UK Ltd) | |
Seroquel XL 300mg tablets (Luye Pharma Ltd) | |
Seroquel XL 300mg tablets (Sigma Pharmaceuticals Plc) | |
Sondate XL 300mg tablets (Teva UK Ltd) | |
Zaluron XL 300mg tablets (Fontus Health Ltd) | |
Virtual Medicinal Product Packs | |
Quetiapine 300mg modified-release tablets 30 tablet | |
Quetiapine 300mg modified-release tablets 60 tablet |
dm+d data retrieved from TRUD: release NHSBSA_11.1.0_20241111000001, imported on 12th November 2024 at 03:53:04.